Evidence map›Paper›PMID 41023131›Full record

ArticleScientific reports2025

Leveraging underrepresented population data improves interpretation of genetic variants associated with hearing loss.

Sun Young Joo, Seung Hyun Jang, Jung Ah Kim, Se Jin Kim, Jae Young Choi, Jinsei Jung, Heon Yung Gee

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sun Young JooDepartment of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.ORCID http://orcid.org/0000-0001-8121-9714
Seung Hyun JangDepartment of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.ORCID http://orcid.org/0009-0002-1147-1476
Jung Ah KimDepartment of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.ORCID http://orcid.org/0000-0002-1264-8328
Se Jin KimDepartment of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea.ORCID http://orcid.org/0009-0006-5244-4887
Jae Young ChoiWon-Sang Lee Institute for Hearing Loss, Seoul, 03722, Republic of Korea.ORCID http://orcid.org/0000-0001-9493-3458
Jinsei JungWon-Sang Lee Institute for Hearing Loss, Seoul, 03722, Republic of Korea. jsjung@yuhs.ac.ORCID http://orcid.org/0000-0003-1906-6969
Heon Yung GeeDepartment of Pharmacology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, 03722, Republic of Korea. hygee@yuhs.ac.ORCID http://orcid.org/0000-0002-8741-6177

Funding

Korea Health Industry Development Institute RS-2024-00346485Korea Health Industry Development Institute RS-2024-00438709National Research Foundation of Korea RS-2024-00400118
6 · The paper itself

Abstract

Hearing loss is genetically heterogeneous, with over 121 implicated genes. Minor allele frequency (MAF) data from population databases greatly aid variant interpretation; however, these databases are predominantly based on individuals of European ancestry and lack sufficient East Asian representation, limiting accurate interpretation in under-represented populations. We analyzed rare variants associated with non-syndromic hearing loss classified as pathogenic, likely pathogenic, or of uncertain significance in the Deafness Variation Database (DVD). Population allele frequencies from 9,579 Koreans, 54,000 Japanese, and 651 patients with sensorineural hearing loss were evaluated. Of the 6,381 pathogenic or likely pathogenic variants cataloged in the DVD, 216 (3.38%) were detected in Korean population. Among these, 31 variants exhibited high allele frequencies that exceeded thresholds typically applied to identify benign variants in clinical interpretation guidelines. Of these, 6 remained disease-causing, including 4 East Asian founder alleles and one MYO7A variant common in Koreans. Our pipeline identified 24 variants for reclassification as benign or likely benign, and one P2RX2 variant of uncertain significance. Of 1,299,211 VUS, 3,736 were reclassified as benign. A substantial number of variants previously classified as pathogenic were reclassified as benign using MAF data from under-represented populations, highlighting the need for large-scale sequencing in diverse ancestries.

Indexed as

Genetic Predisposition to DiseaseGenetic VariationHearing LossHearing Loss, SensorineuralAllelesDatabases, GeneticEast Asian PeopleGene FrequencyHumansRepublic of KoreaClinical variant interpretationNon-syndromic hearing lossPopulation databasesUnder-represented populationsVariant reclassification

Identifiers

PMID41023131
PMCPMC12480851

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.